Skip to main content
. 2010 Apr 21;91(6):1791–1800. doi: 10.3945/ajcn.2009.28639

TABLE 1.

Total mortality rates by baseline participant characteristics, western Washington, 2000–20061

Subjects (n = 77,673)
Person-years (n = 387,801)2
Deaths (n = 3577)
No. of deaths/1000 person-years
Characteristic n Percentage n Percentage n Percentage
Sex
 F 40,308 52 202,169 52 1514 42 7.49
 M 37,365 48 185,633 48 2063 58 11.11
Age at baseline
 50 to <55 y 17,952 23 91,245 24 263 7 2.88
 55 to <60 y 17,566 23 87,978 23 419 12 4.76
 60 to <65 y 14,121 18 70,450 18 533 15 7.57
 65 to <70 y 12,834 17 63,647 16 789 22 12.40
 70 to <77 y 15,200 20 74,481 19 1573 44 21.12
Race-ethnicity
 White 71,096 92 355,127 92 3276 92 9.22
 Hispanic 669 1 3330 1 16 0 4.80
 Black 990 1 4872 1 61 2 12.52
 American Indian/Alaska Native 1152 1 5729 1 59 2 10.30
 Asian or Pacific Islander 1937 2 9751 3 66 2 6.77
 Other/missing 1829 2 8992 2 99 3 11.01
Marital status
 Married 57,212 74 286,458 74 2390 67 8.34
 Living with a partner 1986 3 10,010 3 76 2 7.59
 Separated or divorced 8943 12 12,521 3 442 13 9.99
 Widowed 5570 7 44,250 11 469 13 17.07
 Never married 2514 3 27,470 7 119 3 9.50
 Missing 1448 2 7092 2 81 2 11.42
Education
 Grade school/some high school 2702 3 13,194 3 295 8 22.36
 High school or GED 12,747 16 63,471 16 825 23 13.00
 Some college/technical school 29,237 38 145,763 38 1388 39 9.52
 College graduate 18,677 24 93,655 24 656 19 7.00
 Advanced degree 12,978 17 65,205 17 334 9 5.12
 Missing 1332 2 6513 2 79 2 12.13
Cigarette smoking
 Nonsmoker 39,041 50 196,707 51 1071 30 5.44
 Current smoker
  1 to <20 y 1261 2 6314 2 48 1 7.60
  20 to <40 y 2047 3 10,195 3 131 4 12.85
  ≥40 y 3177 4 14,912 4 422 12 28.30
 Former smoker
  Quit <10 y ago
   1 to <20 y 597 1 3010 1 23 1 7.64
   20 to <40 y 1693 2 8446 2 79 2 9.35
   ≥40 y 2843 4 13,748 4 294 8 21.38
  Quit ≥10 y ago
   1 to <20 y 15,080 19 75,575 19 534 15 7.07
   20 to <40 y 7655 10 38,031 10 453 13 11.91
   ≥40 y 3327 4 15,930 4 439 12 27.56
 Missing 1012 1 4933 1 83 2 16.83
Physical activity in the 10 y before baseline
 None 11,500 15 56,917 15 816 23 14.34
 Quartile 1: >0–3.0 MET-h 16,325 21 81,248 21 881 25 10.84
 Quartile 2: 3.1–8.1 MET-h 16,406 21 81,943 21 700 20 8.54
 Quartile 3: 8.2–17.8 MET-h 16,117 21 80,656 21 612 17 7.59
 Quartile 4: 17.9–157.3 MET-h 16,234 21 81,677 21 500 14 6.12
 Missing 1091 1 5361 1 68 2 12.68
Self-rated health
 Excellent 11,279 15 57,249 15 149 4 2.60
 Very good 29,273 38 147,832 38 685 19 4.63
 Good 27,395 35 136,902 35 1302 36 9.51
 Fair 8212 11 39,450 10 977 27 24.77
 Poor 1514 2 6369 2 464 13 72.86
Morbidity score3
 Level 1 (≤0) 35,466 46 179,929 46 616 17 3.42
 Level 2 (>0–0.5) 27,916 36 139,999 36 1015 29 7.25
 Level 3 (>0.5–1.0) 7733 10 37,899 10 644 18 16.99
 Level 4 (>1.0–1.5) 3978 5 18,827 5 586 16 31.13
 Level 5 (>1.5–2.0) 1397 2 6203 2 334 9 53.85
 Level 5 (>2.0–2.5) 503 1 2116 1 157 4 74.18
 Level 6 (>2.5–3.0) 256 0 960 0 117 3 121.87
 Level 7 (>3.0) 192 0 715 0 89 3 124.47
 Missing 232 0 1153 0 19 1 16.48
1

GED, general equivalency diploma; MET-h, metabolic equivalent task hours.

2

Because of rounding, the numbers of person-years across strata of a variable do not always sum to 387,801.

3

By using Cox regression, the following conditions, categorized as yes or no, were modeled simultaneously in sex-specific and age-adjusted models to obtain the morbidity score: current use of medication for depression or anxiety; current use of blood pressure medication; a history of lung cancer, colon cancer, bladder cancer, leukemia, pancreatic cancer, non-Hodgkin lymphoma, melanoma, prostate cancer, breast cancer, cervical cancer, uterine cancer, ovarian cancer, and all other cancers combined; ischemic heart disease (defined as a previous heart attack), coronary bypass surgery, angioplasty, or diagnosis of angina; stroke; congestive heart disease; rheumatoid arthritis; diabetes; viral hepatitis; cirrhosis of the liver; other chronic liver disease; emphysema, chronic bronchitis, or chronic obstructive pulmonary disease; kidney disease; ulcerative colitis or Crohn disease; Parkinson disease; and osteoporosis in women.